ARTICLE | Company News
Cerus other research news
August 2, 2004 7:00 AM UTC
CERS received a 3-year $3.8 million grant from the National Institute of Allergy and Infectious Diseases to develop an anthrax vaccine. The company said it would receive about $1.4 million for the fir...